People with diabetes are forced to inject insulin into muscle tissue. Pharmacological preparations of this group are analogues of a substance produced by the human body, or neutral substances of animal origin.
Indications for the use of short-acting insulin
A drug is needed in the case of:
- type 1 diabetes;
- stage of resistance in type 2 diabetes;
- if the diet is ineffective during pregnancy;
- hyperglycemic coma .
Short-acting insulin preparations
To preparations of an animal origin carry:
- Actrapid MS;
- Iletin II Regular;
- Insulrape SPP;
- Monolin Regulator U240;
- Brinsularpis MK;
- Monosuansulin MK;
- Pensulin SR.
Short-acting insulin is injected into the subcutaneous fat layer and after 15-30 minutes it provides rapid transportation of amino acids and glucose to the cells. The duration of influence is 6-8 hours. However, the peak activity of the substance is only 1-3 hours.
Below are the names of insulin preparations of short action, similar to human.
Quick preparations:
- Actrapid NM;
- Biogulin Regulator;
- Berlinersulin N Normal;
- Brinsularpie Ch;
- Biosulin P;
- Insuman Rapid;
- Pensulin Czech Republic;
- Humulin Regular;
- Homorap.
Already after 15-30 minutes the action of the drug begins. The duration of the work is 5-8 hours, the peak of activity is 1-3 hours.
Superfast insulin of ultrashort action:
- Apidra;
- Novararapid;
- Humalog.
The difference of this group is that the properties of the drug manifest themselves after 15 minutes. The duration of action is not more than 3-5 hours. The peak of activity is 0.5-2.5 hours.
The time of active action of a short insulin is directly connected with several moments. These include factors such as the injection site, dosage and anatomical features of the patient.
Drugs are produced in vials, as well as special cartridges. Insulin in
Optimum short-acting insulin is administered before meals in 10-30 minutes, not forgetting to change the site for injection every time. The substance in vials can be used in combination, mixing with long-acting preparations. In this case, the combined preparation is administered immediately after mixing the components. All short-acting insulins are released only after the presentation of the prescription.